在中国改革开放 40 周年之际,由广东省健康管理学会、上海市免疫学会、深圳市医学会联合主办,深圳市福田区风湿病专科医院和上海交通大学医学院附属仁济医院共同承办的的「一带一路·粤港澳大湾区自身免疫病高峰论坛暨深圳·2018 国际自身免疫病前沿论坛」, 将于 2018 年 10 月 13 日-14 日在深圳福朋喜来登酒店隆重召开。

"目录号: HY-14658

自身免疫病是人类健康的重大威胁,可累及全身所有器官,发病机制复杂,诊断和治疗十分具有挑战性。免疫学研究的飞速进展给自身免疫病的诊治带来了新的曙光。本次会议将邀请来自美国、加拿大、印度、菲律宾、中国香港、中国澳门及中国内地大湾区及各省市的免疫学、风湿病学和流行病学等各领域知名专家分享基础免疫学和临床免疫学的最新进展,探索临床研究和药理研究的新理念。

Others-

新的历史时期,在国家「一带一路」建设倡议的略大布局中,粤港澳地区被赋予 21 世纪海上丝绸之路建设的排头兵和主力军重任。我们将以此次会议为契机,秉承「创新转化、合作共赢」,执行「一带一路」方针政策的宗旨,搭建一个学术争鸣和科研共建的平台,推进粤港澳地区与国际的交流合作,助力大湾区医学事业发展,促进「健康中国」战略实施。

Thalidomide能抑制由bFGF或VEGF诱导的体内血管生成。

本次大会将同时举办本次大会将同时举办第三届仁济自身免疫病高峰论坛、第七届深莞惠三地风湿病学术论坛、2018 年深圳市医学会风湿病专业委员会学术年会及深圳市风湿免疫专科医联体联盟授牌仪式。

Others

十月的南中国,金秋送爽,桂花飘香,让我们相聚美丽的深圳。诚邀您参与会,一道参加「一带一路·粤港澳大湾区自身免疫病高峰论坛暨深圳·2018 国际自身免疫病前沿论坛」学术盛宴,共同创造美好的明天。

相关产品

一、会议时间:2018 年 10 月 13 日-14 日

SBE-β-CD-MPTP hydrochloride-Cyclosporin A-Etomoxir-Auranofin-GKT137831-Ceruletide-Acetylcysteine-JC-1-BPTES-Brassinolide-FCCP-IPTG-MTT-RSL3 1S,3R--

二、会议地点:深圳福朋喜来登酒店四楼深圳厅,地址:深圳市福田区桂花路 5 号(临近地铁 4 号线福田口岸地铁站 B 出口)

生物活性

三、参会事项:

Description

1)注册费 1200 元,含住宿及餐费、注册包等。(10月10日之后报名尽量安排会议酒店,如会议酒店房间预订满将协助安排附近酒店入住)

Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.IC50 value:Target:Thalidomide was commonly used therapeutically in the late 1950's; however, it was withdrawn from the market when it was discovered to cause birth defects. More recent research has found Thalidomide to affect key biochemical pathways yielding antiangiogenic and immunomodulatory activities. This compound has been shown to: selectively inhibit tumor necrosis factor-alpha (TNF alpha) biosynthesis and basic fibroblast growth factor (bFGF)-induced angiogenesis, induce apoptosis in human monocytes via a cytochrome c-dependent pathway, and to inhibit HIV-1 replication in a monocytoid (U1) line. These new found uses make Thalidomide an extremely valuable research tool.

生物活性,国际自身免疫性传播病痛前沿论坛」学术盛宴。2)学生半价优惠,含住宿及餐费。

Clinical Trial

3)特殊情况大会主席可酌情优惠,但交通住宿自理。

NCT01485224

4)10 月 14 日全程参与者授予 II 类学分 1.5 分。

IRCCS Policlinico S. Matteo

四、联系方式:

Hereditary Hemorrhagic Telangiectasia-Epistaxis

曾医生:+86 135 0940 6135

November 2011

尹医生:+86 159 8668 6069

Phase 2

报名邮箱:szfsbxh@126.com

NCT00953615

会议议程

Mayo Clinic-Celgene Corporation

一带一路·粤港澳大湾区自身免疫病高峰论坛暨深圳·2018 国际自身免疫病前沿论坛

Primary Sclerosing Cholangitis

第三届仁济自身免疫病高峰论坛暨风湿专科联盟标准化样本库建设研讨会

April 2006

日 程 表

Phase 2

(2018年10月14日 地点:深圳福朋喜来登酒店)

NCT02956538

10月14日地点:四楼深圳厅

Sixth Affiliated Hospital, Sun Yat-sen University

8:00-8:40

Crohn Disease

报到、注册

October 2016

8:50-9:30

Early Phase 1

开幕式,领导致辞

NCT03184844

深圳市风湿病专科医联体联盟成立授牌仪式

Xiao-Lin Yin-303rd Hospital of the People's Liberation Army

领导嘉宾合影

Thalassemia

10月14日上午 地点:四楼深圳厅

May 2, 2017

时间

Phase 2

题目

NCT02995707

讲者

Xiao-Lin Yin-303rd Hospital of the People's Liberation Army

主持

Thalassemia

9:35-10:05

September 2016

A Repeat Offender: Epstein-Barr virus in autoimmunity & other disease mechanisms(重复侵犯:Epstein-Barr病毒在自身免疫和其他疾病中的作用机制)

Phase 2

John B. Harley

NCT00856804

沈南

Valme University Hospital-University of Seville

朱平

Hepatitis C

10:05-10:35

March 2009

Novel insights on scleroderma &fibrosis

Phase 2

(硬皮病和纤维化的新见解)

NCT00038233

Mohit Kapoor

M.D. Anderson Cancer Center-Celgene Corporation

张跃

Multiple Myeloma

杨万岭

May 1999

10:35-10:45

Phase 3

茶歇

NCT00600028

10:45-11:15

Johns Hopkins University

Indo-China: Emerging global capital of medical science - why and how

Idiopathic Pulmonary Fibrosis-Cough

(大动脉炎-分享我们的经验)

December 2007

Debashish Danda (印度韦洛尔基督教医学院)

Phase 3

厉小梅

NCT00142116

王庆文

Steven P. Treon, MD, PhD-Dana-Farber Cancer Institute-Massachusetts General Hospital-Beth Israel Deaconess Medical Center-Brigham and Women's Hospital-Cape Cod Healthcare

11:15-11:45

Waldenstrom's Macroglobulinemia-Lymphoplasmacytic Lymphoma

Current and future therapies for SLE: Where are we now and how to proceed from here?

May 2003

(系统性红斑狼疮治疗的现状和未来)

Phase 2

Sandra V. Navarra (菲律宾圣托马斯大学)

NCT03208413

林禾

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

吴恒莲

Radiation Injuries

12:00-13:00

July 19, 2017

午餐会

Phase 2

10月14日下午 地点:四楼香港厅

NCT02778893

13:00-13:20

Henan Provincial Hospital

类风湿关节炎的药理研究新探索

NSCLC

朱依淳

March 2016

胡绍先

Phase 4

谭志明

NCT00657488

13:20-13:40

Celgene Corporation

红斑狼疮肾炎治疗之最新进展

Multiple Myeloma

莫志超

December 2001

陈国强

Phase 2-Phase 3

区冰玲

NCT01937442

13:40-14:00

Celgene Corporation

中医诊治SLE的思考与实践

Multiple Myeloma

范永升

November 2013

侯丽君

Phase 1

何善智

UEDBET西甲赫塔菲 ,NCT01924624

14:00-14:20

The First Affiliated Hospital of Xiamen University

炎症与软骨保护

Hepatocellular Carcinoma-Recurrence

张志毅(哈尔滨医科大学附属第一医院)

July 2013

韦锋

NCT01638078

胡学军

University of Roma La Sapienza

14:20-14:40

Coronary Artery Disease

2018年SLE新进展

January 2014

杨念生(中山大学附属第一医院)

Phase 4

吴华香

NCT01061866

史冉庚

National Institute of Neurology and Neurosurgery, Mexico-National Council of Science and Technology, Mexico

14:40-15:00

Refractory Epilepsy

RA二线治疗首选,强效靶向DMARDs药物托法替布

June 2006

李梦涛

Phase 1-Phase 2

何东仪肖学吕

NCT00373646

15:00-15:10

Medical University of Vienna

茶歇

MALT Lymphoma

15:10-15:35

June 2006

Complementary and Integrative Health Approaches for Chronic Rheumatic Diseases and Well-being(针对慢性风湿病和健康的补充和综合健康方法)

Phase 2

Chenchen Wang

NCT03016000

(美国塔夫茨大学医学院)

Nanfang Hospital of Southern Medical University

张剑勇

Lymphoma, Large B-Cell, Diffuse

张丽君

February 2017

15:35-15:55

Phase 3

重视骨关节炎的研究

NCT00964496

黄慈波

Shanghai Jiao Tong University School of Medicine

黎德育李博

Obscure Gastrointestinal Bleeding-Angiodysplasia-Gastric Antral Vascular Ectasia-Thalidomide

15:55-16:15

November 2004

痛风的诊断和治疗进展

Phase 2

戴冽(中山大学孙逸仙纪念医院)

NCT00966693

许赤多

M.D. Anderson Cancer Center-Celgene

潘富林

Myeloma

16:15-16:35

August 2009

TNF拮抗剂安全性与管理

Phase 1-Phase 2

王庆文

NCT00921531

郭成山

Fudan University

潘志铣

Hepatocellular Carcinoma

16:35-16:55

June 2009

肿瘤免疫治疗——风湿科医生面临的新挑战

Phase 3

陈盛

NCT02754960

李永柏

Shanghai Jiao Tong University School of Medicine

郑智华

Gastrointestinal Hemorrhage-Vascular Malformation

16:55-17:15

March 2010

SpA最新研究进展

Phase 2

陈盛

NCT02203253

17:15-17:30

China Medical University, China-The First Hospital of Liaoning Medical University-The First Affiliated Hospital of Dalian Medical University-The Second Affiliated Hospital of Dalian Medical University-Liaoning Tumor Hospital & Institute-Shengjing Hospital-General Hospital of Shenyang Military Region-Liaoyang Central Hospital-Third People's hospital Liaoyang-Petrochemical General Hospital of Liaoyang city-Anshan Tumor Hospital

深圳市医学会风湿病专委会总结

Neoplasms

叶志中

July 2014

(注:会议日程安排如有变动,请以当日会场公告

Phase 3

The Belt and Road · the Guangdong-Hong Kong-Macao Greater Bay Area Autoimmune Disease Summit Forum

NCT01028781

2018 International Autoimmune Disease Frontier Forum

University of North Carolina, Chapel Hill-Celgene Corporation

The Third Renji Autoimmune Disease Summit Forum

Endometriosis

Conference Schedule

October 2006

Saturday, October 13, 2018 Location: Four Points By Sheraton Shenzhen A Hall

Phase 1

Time

NCT00519688

Topic

National Taiwan University Hospital

Speaker

Hepatocellular Carcinoma

Moderator

July 2006

13:30-14:00

Phase 2

register

NCT00140452

14:00-14:20

Dartmouth-Hitchcock Medical Center-Celgene Corporation

The Licensing Ceremony of Renji Rheumatology Alliance

Amyotrophic Lateral Sclerosis-ALS

Prof. SHEN Nan

February 2005

(Renji Hospital, Shanghai Jiao Tong University School of Medicine)

Phase 2

Prof. GUO Qiang

NCT01296503

14:20-15:00

Grupo de Estudos Multicentricos em Onco-Hematologia

Conduct clinical research on daily medical data

Multiple Myeloma

Prof.PENG Xianxia

October 2003

(Beijing Children’s Hospital, Capital Medical University)

Phase 3

Prof. ZHU Xiaochun

NCT00083577

15:00-15:40

University of Arkansas

AOSD and MAS (Shanghai Medicine & Medicine Sales Special)

Multiple Myeloma

Prof.LV Liangjing

February 1998

(Renji Hospital, Shanghai Jiao Tong University School of Medicine)

Phase 2

Prof. LI Zhijun

NCT00450008

15:40-16:00

The Methodist Hospital System-Bayer

Coffee/Tea Break

Prostatic Neoplasms

16:00-16:30

December 2006

References to evidence-based research from RA guidelines change (Pfizer's Special)

Phase 2

Prof. GUO Qiang

NCT02201043

(Renji Hospital, Shanghai JIAO TongProf.

Shanghai Pharmaceuticals Holding Co., Ltd

University School of Medicine)

Ankylosing Spondylitis

Prof. WAN Weiguo

February 2013

16:30-17:00

Phase 2

Management of chronic rheumatic disease and its effect on clinical practice

NCT00022581

Prof.LI Ting (Renji Hospital, Shanghai Jiao Tong University School of Medicine)

National Cancer Institute (NCI)

Prof. XU Liang

Recurrent Grade 1 Follicular Lymphoma-Recurrent Grade 2 Follicular Lymphoma-Recurrent Grade 3 Follicular Lymphoma-Recurrent Small Lymphocytic Lymphoma

17:00-17:30

July 2001

The standardization of biobanking and national network is imperative

Phase 2

Prof.GAO Hengjun (Biochip Shanghai Bational Center)

NCT00083707

Prof. TGANG Jianping

University of Arkansas-Celgene Corporation

Sunday, October 14, 2018 Location: Four Points By Sheraton Shenzhen Hall

Waldenstrom Macroglobulinemia

Time

January 1999

Topic

Phase 2

Speaker

NCT00305552

Moderator

Assistance Publique - Hôpitaux de Paris

8:00-8:40

Sarcoidosis

register

February 2005

8:50-9:30

Phase 3

Opening Ceremony

NCT03069326

The Establishment and licensing ceremony of Shenzhen Rheumatology Medical Association Alliance

Memorial Sloan Kettering Cancer Center-Incyte Corporation-Celgene-M.D. Anderson Cancer Center

Group Photo of Leaders and Guests

Myelofibrosis

9:35-10:05

February 27, 2017

A Repeat Offender: Epstein-Barr virus in autoimmunity & other disease mechanisms

Phase 2

PROF. John B. Harley,( University of Cincinnati,USA )

NCT02649101

SHEN Nan

Zhejiang Cancer Hospital

ZHU Ping

Metastatic Breast Cancer

10:05-10:35

October 2015

Novel insights on scleroderma &fibrosis

Phase 2

PROF. Mohit Kapoor, ( University of Toronto,Canada )

NCT01976195

ZHANG Yue

Shandong University-The Affiliated Hospital of the Chinese Academy of Military Medical Sciences-Anhui Medical University-The First Affiliated Hospital of Dalian Medical University-Shenzhen Second People's Hospital

YANG Wanling

Immune Thrombocytopenia

10:35-10:45

October 2013

Tea Break

Phase 2

10:45-11:15

NCT00038246

Takayasu arteritis - sharing our experience

M.D. Anderson Cancer Center-Celgene Corporation

PROF. Debashish Danda,( Christian Medical College & Hospital, Vellore, India )

Prostate Cancer

LI Xiaomei

October 2000

WANG Pingwen

Phase 1-Phase 2

11:15-11:45

NCT01551641

Current and future therapies for SLE: Where are we now and how to proceed from here?

Changzhou No.2 People's Hospital

PROF. Sandra V. Navarra, ( University of Santo Tomas, Philippines)

Esophageal Cancer

LIN He

January 2012

WU Henglian

Phase 2

12:00-13:00

NCT00720538

Roche Satellite Symposium(Hongkong Hall A )

IRCCS Burlo Garofolo-Ospedale Meyer-Pediatric Gastroenterology Unit, IRCCS Gaslini, Genoa.-Vittore Buzzi Children's Hospital-University of Pisa-University of Messina-Università degli Studi di Brescia-University of Trieste

PROF. Janssen Satellite Symposium,(Hongkong Hall B )

Inflammatory Bowel Diseases-Crohn's Disease-Ulcerative Colitis

Sunday, October 14, 2018 Location: Four Points By Sheraton Hongkong Hall

August 2008

Time

Phase 3

Topic

NCT00787436

Speaker

The Cleveland Clinic-Celgene Corporation

Moderator

Gastrointestinal Hemorrhage-Portal Hypertension

13:00-13:20

May 2006

Novel exploring on pharmacology of rheumatoid arthritis

Phase 3

PROF. Zhu Yizhun ,

NCT00049296

( Macau University of Science and Technology )

Case Comprehensive Cancer Center-National Cancer Institute (NCI)

Prof. HU Shaoxian

Cancer

Prof. TAN Zhiming

July 2002

13:20-13:40

Phase 1

Update on the therapy of lupus nephritis

NCT02501291

PROF. Chi Chiu MOK,

First Affiliated Hospital, Sun Yat-Sen University

( Tuen Mun Hospital, Hong Kong SAR )

Crohn's Disease

Prof. CHEN Guoqiang

January 2013

Prof. OU Bingling

Phase 2

13:40-14:00

NCT01242267

Thinking and clinical practice of TCM diagnosis and treatment of SLE

Hackensack University Medical Center-Millennium Pharmaceuticals, Inc.

PROF. Fan Yongsheng,

Multiple Myeloma

(Zhejiang Chinese Medical University )

April 2010

Prof. HOU LiJun

Phase 1-Phase 2

Prof. HE Shangzhi

NCT00218855

14:00-14:20

Norwegian University of Science and Technology-The Research Council of Norway-Nordic Myeloma Study Group, Germany

Inflammation and cartilage protection

Multiple Myeloma

PROF. Zhang Zhiyi,

January 2002

( The First Affiliated Hospital of Harbin Medical University )

Phase 3

Prof. WEI Feng

NCT00769587

Prof. HU Xuejun

Centre Hospitalier Universitaire, Amiens

14:20-14:40

Non Neoplastic Condition-Precancerous Condition

New progress in SLE in 2018

June 2007

PROF.Yang Niansheng,

Phase 2

( The First Affiliated Hospital of Sun Yat-sen University )

NCT01891019

Prof. WU HuaXiang

Wake Forest University-Wake Forest University Health Sciences

Prof. SHI Rangeng

Psoriasis, Plaque-type

14:40-15:00

April 2003

Tofacitinib: a highly effective DMARDs drug and the first choice for second-line RA treatment

Phase 2

PROF. Li Mengtao ,

NCT00057564

( Peking Union Medical College Hospital )

Celgene Corporation-Celgene

Prof. HE Dongyyi

Multiple Myeloma

Prof. XIAO XueLv

February 2003

15:00-15:10

Phase 3

Coffee/Tea Break

NCT00015990

15:10-15:35

National Cancer Institute (NCI)

Complementary and Integrative Health Approaches for Chronic Rheumatic Diseases and Well-being

PROF.Chenchen Wang,

(Tufts University School of Medicine,USA )

Prof. ZHANG Jianyong

Prof. ZHANG Lijun

15:35-15:55

Pay attention to the study of osteoarthritis

PROF.Huang Cibo,

( Beijing Hospital )

Prof. Li Deyue

Prof. Li Bo

15:55-16:15

Progress in the Diagnosis and Treatment of Gout

PROF.Dai Lie,( Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University )

Prof. XU Chiduo

Prof. PAN Fulin

16:15-16:35

Safety and management of TNF Antagonist

PROF.Wang Qingwen,( Peking University Shenzhen Hospital )

Prof. GUO Chengshan

Prof. PAN Zhixian

16:35-16:55

Immunotherapy of tumors -- a new challenge for rheumatologists

PROF.CHEN Sheng, ( Renji Hospital, Shanghai Jiao Tong University School of Medicine )

Prof. LI Yongbai

Prof. ZHENG Zhihua

16:55-17:15

Latest Research Progress of SpA

PROFESSO CHEN Sheng,( Renji Hospital, Shanghai Jiao Tong University School of Medicine )

17:15-17:30

Summary of the Rheumatology special committee of Shenzhen medical association

PROF.Ye Zhizhong, ( Shenzhen Futian Hospital for Rheumatic Diseases)

Prof.ZHUANG Junhan

(Note:If there is any change in the meeting schedule, please refer to the notice of the meeting venue on that day)

PLEASE NOTE:Delegates and invitees must be seated by 13:00 pm.

精彩不容错过:会议直播直通车